Kaiser Permanente chairman and chief executive officer Bernard J. Tyson dies at 60; vitamin E acetate is linked as a potential cause of vaping-related lung injuries; Medicare’s outpatient premium cost is rising.
Bernard J. Tyson, chairman and chief executive officer (CEO) of the health plan provider Kaiser Permanente, died unexpectedly in his sleep yesterday at the age of 60, reported USA Today. The news came after Tyson had spoken 1 day earlier at a tech gathering called AfroTech in Oakland, California. Kaiser Permanente issued a statement late Sunday evening stating, “On behalf of our Board of Directors, employees, and physicians, we extend our deepest sympathies to Bernard’s family during this very difficult time.” Tyson became the head of Kaiser Permanente in 2013 and had worked at the company for over 30 years.
Health officials at the CDC announced on Friday that there has been a breakthrough in the investigation of vaping-related lung injuries, as the chemical compound vitamin E acetate was found in all samples of lung fluid collected from 29 patients who were hospitalized for vaping, according to NPR. The vaping outbreak, which has led to the deaths of 39 people and sickened more than 2000 others, had been linked in hundreds of patients to the use of THC, the main psychoactive component of marijuana. Anne Schuchat, MD, CDC’s principal deputy director, told reporters on a press call that “vitamin E acetate is a known additive used to dilute liquid in e-cigarettes or vaping products that contain THC,” said Schuchat.
Medicare’s Part B premium for outpatient care is set to rise next year by nearly 7% to $144.60 a month next year, according to the Associated Press. Officials blamed the premium increase largely on rising spending for drugs administered in doctors’ offices, which are covered under the Part B outpatient benefit and include many cancer drugs. The $9.10 monthly increase follows a smaller $1.50 rise this year and comes after Social Security announced a modest cost-of-living raise for 2020 that comes out to approximately $24 a month for the average retired worker.
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
2 Commerce Drive
Cranbury, NJ 08512